PDS Biotechnology Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Frank K. Bedu-Addo, with a market cap of $61.4M.
Based on Q1 2026 filing
Common questions about PDS Biotechnology Corporation
PDS Biotechnology Corporation (PDSB) has a market capitalization of $61.4M and trades on NASDAQ.
PDS Biotechnology Corporation has approximately 25 employees.